ZA200609635B - Mitochondrially targeted antioxidants in the treatment of liver diseases and epithelial cancers - Google Patents
Mitochondrially targeted antioxidants in the treatment of liver diseases and epithelial cancersInfo
- Publication number
- ZA200609635B ZA200609635B ZA200609635A ZA200609635A ZA200609635B ZA 200609635 B ZA200609635 B ZA 200609635B ZA 200609635 A ZA200609635 A ZA 200609635A ZA 200609635 A ZA200609635 A ZA 200609635A ZA 200609635 B ZA200609635 B ZA 200609635B
- Authority
- ZA
- South Africa
- Prior art keywords
- treatment
- liver diseases
- epithelial cancers
- mitochondrially targeted
- targeted antioxidants
- Prior art date
Links
- 201000009030 Carcinoma Diseases 0.000 title 1
- 239000003963 antioxidant agent Substances 0.000 title 1
- 208000019423 liver disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04103318 | 2004-07-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200609635B true ZA200609635B (en) | 2008-08-27 |
Family
ID=34929318
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200609635A ZA200609635B (en) | 2004-07-13 | 2006-11-20 | Mitochondrially targeted antioxidants in the treatment of liver diseases and epithelial cancers |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20070225255A1 (xx) |
| EP (1) | EP1765413A2 (xx) |
| JP (1) | JP2008506667A (xx) |
| CN (1) | CN1997403A (xx) |
| AU (1) | AU2005261654A1 (xx) |
| CA (1) | CA2573456A1 (xx) |
| IL (1) | IL179738A0 (xx) |
| RU (1) | RU2007105138A (xx) |
| SG (1) | SG156613A1 (xx) |
| WO (1) | WO2006005759A2 (xx) |
| ZA (1) | ZA200609635B (xx) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2631152T3 (es) | 2004-01-22 | 2017-08-28 | University Of Miami | Formulaciones de coenzima Q10 tópicas o intravenosas para su uso en el tratamiento del cáncer |
| US20080032940A1 (en) * | 2006-08-07 | 2008-02-07 | Balaraman Kalyanaraman | Methods for reducing anthracycline-induced toxicity |
| EP2119436A4 (en) | 2006-10-20 | 2010-03-03 | Ltd Liability Company Mitotech | PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF EYE DISEASES |
| EA200900583A1 (ru) | 2006-10-20 | 2009-08-28 | Общество С Ограниченной Ответственностью "Митотехнология" | Композиция для регенерации, стимуляции роста и адаптации растений к различным стрессовым факторам |
| US8349902B2 (en) | 2007-01-29 | 2013-01-08 | Mitotech Sa | Pharmaceutical compositions useful for preventing and treating oncological diseases |
| US9427444B2 (en) | 2007-01-29 | 2016-08-30 | Mitotech Sa | Pharmaceutical and cosmetic compositions for accelerated healing of wounds and other surface damages |
| EA201000142A1 (ru) | 2007-04-11 | 2010-04-30 | Общество С Ограниченной Ответственностью "Митотехнология" | Композиция, замедляющая старение и увеличивающая продолжительность жизни организма, и ее применение |
| US8518915B2 (en) | 2007-06-29 | 2013-08-27 | Mitotech Sa | Use of mitochondrially-addressed compounds for preventing and treating cardiovascular diseases |
| AU2008296012A1 (en) * | 2007-09-07 | 2009-03-12 | Gencia Corporation | Mitochondrial compositions and uses thereof |
| US8388936B2 (en) * | 2008-02-22 | 2013-03-05 | Mcw Research Foundation, Inc. | In vivo mitochondrial labeling using positively-charged nitroxide enhanced and gadolinium chelate enhanced magnetic resonance imaging |
| US8388931B2 (en) * | 2008-02-29 | 2013-03-05 | Marcos Lopez | 99m Tc-labeled triphenylphosphonium derivative contrasting agents and molecular probes for early detection and imaging of breast tumors |
| EP2271325A4 (en) | 2008-04-11 | 2011-11-09 | Cytotech Labs Llc | METHODS AND USE OF INDUCING APOPTOSIS IN CANCER CELLS |
| US9308214B2 (en) | 2008-11-12 | 2016-04-12 | Mitotech S.A. | Method for moderately increasing the proton conductivity of biological membranes with the aid of mitochondria-targeted delocalized cations |
| CA2756820A1 (en) * | 2009-04-17 | 2010-10-21 | Colby Pharmaceutical Company | Pharmaceutically active compositions comprising oxidative stress modulators (osm), new chemical entities, compositions and uses |
| US10519504B2 (en) | 2009-05-11 | 2019-12-31 | Berg Llc | Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers |
| EP2823814A1 (en) | 2009-06-10 | 2015-01-14 | Mitotech SA | Pharmaceutical composition for use in medical and veterinary ophthalmology |
| KR20120125980A (ko) | 2009-11-13 | 2012-11-19 | 리미티드 라이어빌러티 컴퍼니 미토테크 | 미토콘드리아 표적화된 항산화제에 기초한 약학적 물질 |
| EP2694463B8 (en) | 2011-04-04 | 2019-10-09 | Berg LLC | Treating central nervous system tumors with coenzyme q10 |
| CN103764132B (zh) | 2011-06-03 | 2017-04-12 | 米托特克公司 | 线粒体靶向的抗氧化剂的口服制剂及其制备和用途 |
| EP2758411A2 (en) * | 2011-09-19 | 2014-07-30 | Gencia Corporation | Modified creatine compounds |
| EA032775B1 (ru) | 2013-04-08 | 2019-07-31 | Берг Ллк | Способы лечения злокачественной опухоли с использованием комбинированной терапии с коферментом q10 |
| UA116469C2 (uk) * | 2013-04-24 | 2018-03-26 | Смарт Брейн С.Р.О. | Похідні тамоксифену для лікування новоутворень, особливо з високим рівнем білка her2 |
| WO2015035094A1 (en) | 2013-09-04 | 2015-03-12 | Berg Llc | Methods of treatment of cancer by continuous infusion of coenzyme q10 |
| US10058542B1 (en) | 2014-09-12 | 2018-08-28 | Thioredoxin Systems Ab | Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith |
| KR101773404B1 (ko) | 2015-08-25 | 2017-08-31 | (주) 씨유스킨 | 자외선에 의한 피부 손상의 예방 또는 개선을 위한 화장료 조성물 |
| WO2017087576A1 (en) | 2015-11-16 | 2017-05-26 | Berg Llc | Methods of treatment of temozolomide-resistant glioma using coenzyme q10 |
| CN107510848A (zh) * | 2016-06-15 | 2017-12-26 | 常州莱道斯生物医药科技有限公司 | 线粒体靶向制剂MitoPBN在防治糖尿病中的应用 |
| CN108201543A (zh) * | 2016-12-19 | 2018-06-26 | 北京福纳康生物技术有限公司 | 水溶性富勒烯结构在制备治疗脂肪肝的药物中的应用 |
| WO2021198786A1 (en) * | 2020-04-03 | 2021-10-07 | Mitotech S.A. | Use of mitochondria-targeted antioxidants to treat severe inflammatory conditions |
| CN115381804B (zh) * | 2022-08-10 | 2024-06-21 | 华南师大(清远)科技创新研究院有限公司 | 癸基泛醌在制备治疗肝纤维化药物中的应用 |
| CN117563560A (zh) * | 2023-12-06 | 2024-02-20 | 西南大学 | 一种高效去除汞的吸附材料及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9722361D0 (en) * | 1997-10-24 | 1997-12-17 | Pharma Nord Uk Ltd | Pharmaceutical formulation for treating liver disorders |
| US6331532B1 (en) * | 1998-11-25 | 2001-12-18 | University Of Otago | Mitochondrially targeted antioxidants |
| CA2354743A1 (en) * | 2001-08-07 | 2003-02-07 | University Of Otago | Mitochondrially targeted antioxidants |
| NZ513547A (en) * | 2001-08-13 | 2002-09-27 | Antipodean Biotechnology Ltd | Synthesis of triphenylphosphonium quinols (e.g. mitoquinol) and/or quinones (e.g. mitoquinone) |
| CA2536546C (en) * | 2003-08-22 | 2012-10-02 | Antipodean Pharmaceuticals, Inc. | Mitoquinone derivatives used as mitochondrially targeted antioxidants |
-
2005
- 2005-07-12 JP JP2007520833A patent/JP2008506667A/ja not_active Withdrawn
- 2005-07-12 CA CA002573456A patent/CA2573456A1/en not_active Abandoned
- 2005-07-12 RU RU2007105138/15A patent/RU2007105138A/ru unknown
- 2005-07-12 SG SG200906579-8A patent/SG156613A1/en unknown
- 2005-07-12 EP EP05775873A patent/EP1765413A2/en not_active Withdrawn
- 2005-07-12 CN CNA2005800231931A patent/CN1997403A/zh active Pending
- 2005-07-12 US US11/632,149 patent/US20070225255A1/en not_active Abandoned
- 2005-07-12 WO PCT/EP2005/053338 patent/WO2006005759A2/en not_active Ceased
- 2005-07-12 AU AU2005261654A patent/AU2005261654A1/en not_active Abandoned
-
2006
- 2006-11-20 ZA ZA200609635A patent/ZA200609635B/xx unknown
- 2006-11-30 IL IL179738A patent/IL179738A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008506667A (ja) | 2008-03-06 |
| CN1997403A (zh) | 2007-07-11 |
| WO2006005759A3 (en) | 2006-05-11 |
| AU2005261654A1 (en) | 2006-01-19 |
| US20070225255A1 (en) | 2007-09-27 |
| EP1765413A2 (en) | 2007-03-28 |
| WO2006005759A2 (en) | 2006-01-19 |
| SG156613A1 (en) | 2009-11-26 |
| IL179738A0 (en) | 2007-05-15 |
| RU2007105138A (ru) | 2008-08-20 |
| CA2573456A1 (en) | 2006-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200609635B (en) | Mitochondrially targeted antioxidants in the treatment of liver diseases and epithelial cancers | |
| EP1968607A4 (en) | TREATMENT OF CANCER AND OTHER DISEASES | |
| IL184047A0 (en) | Methods and compositions for treating amyloid-related diseases | |
| EP1749095A4 (en) | NEW THERAPEUTIC TARGETS IN CANCER | |
| IL241756A0 (en) | Preparations and methods for the treatment of diseases of safty tumors | |
| IL181608A0 (en) | Cancer combination therapy comprising azd2171 and imatinib | |
| IL227841A0 (en) | Dihydropyridinones for the treatment of cancer | |
| EP1758595A4 (en) | Use of lipid conjugates in the treatment of diseases | |
| EP1737482A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES | |
| IL190332A0 (en) | Human antibodies against il13 and therapeutic uses | |
| IL182498A0 (en) | Therapeutic furopyrimidines and thienopyrimidines | |
| IL182643A0 (en) | Novel composition and methods for the treatment of immune related diseases | |
| IL191072A0 (en) | Therapeutic compositions and methods | |
| IL178012A0 (en) | Diphenyl-indol-2-on compounds and their use in the treatment of cancer | |
| GB0418328D0 (en) | Cancer methods and medicaments | |
| IL182652A0 (en) | Nitrobenzindoles and their use in cancer therapy | |
| EP2012798A4 (en) | USE OF INOSITOL-TRIPYROPHOSPHATE IN THE TREATMENT OF TUMORS AND DISEASES | |
| IL180278A0 (en) | Fused pyrimidones useful in the treatment and the prevention of cancer | |
| ZA200600025B (en) | Methods and compositions for interferon therapy | |
| GB0428170D0 (en) | Mono and Combination Therapy | |
| EP1805210A4 (en) | NOVEL PEPTIDES AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASE | |
| GB0407382D0 (en) | Therapeutic methods and means | |
| EP1778873A4 (en) | NEW THERAPEUTIC TARGETS AGAINST CANCER | |
| EP1755669A4 (en) | METHODS AND COMPOSITIONS FOR SPECIFIC TARGETING OF HEPATOCELLULAR CARCINOMA CELLS IN MAN | |
| EP1973398A4 (en) | USE OF INOSITE TRIPYROPHOSPHATE IN THE TREATMENT OF TUMORS AND DISEASES |